COMPANY PROFILE // THE 014 REPORT
Lycia Therapeutics, Inc.
LYCA (Nasdaq)
Assembled from 3 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 25 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Lycia Therapeutics, Inc. is an SEC-registered company in biological products, (no diagnostic substances), incorporated in DE, based in South San Francisco, CA; listed as LYCA (Nasdaq).[source] It has filed 37 documents with the SEC in the last 12 months; the latest is Form 4, filed 2026-11-04.[source] 25 of 26 lists and sources checked came back clear; the rest are listed with their result.[source]
- red0
- amber0
- info0
- CLEAR25
- POSSIBLE MATCH1
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 25 CLEAR, 1 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001806540 | source |
| EIN | 84-3860514 | source |
| Business address (SEC) | 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
No dated renewal or filing deadline is held for this entity: no SAM registration, no LEI and no periodic filing schedule on record.
PEERS BY SIC CODE
Industry context
SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- AMGEN INC · 123 SEC filings in 12 months · 1 flag · $507.4M federal (possible match)
- Vir Biotechnology, Inc. · 117 SEC filings in 12 months · 1 flag · $65.9M federal (possible match)
- Vericel Corp · 109 SEC filings in 12 months · 1 flag · $37.3M federal (possible match)
- Coherus Oncology, Inc. · 53 SEC filings in 12 months · 3 flags · $11.8M federal (possible match)
- BIO-TECHNE Corp · 77 SEC filings in 12 months · 1 flag · $6.6M federal (possible match)
- Twist Bioscience Corp · 337 SEC filings in 12 months · 2 flags · $5.9M federal (possible match)
- Adaptive Biotechnologies Corp · 185 SEC filings in 12 months · 1 flag · $1.9M federal (possible match)
- AGENUS INC · 82 SEC filings in 12 months · 3 flags · $613K federal (possible match)
- REPLIGEN CORP · 89 SEC filings in 12 months · 1 flag · $457K federal (possible match)
- Revolution Medicines, Inc. · 171 SEC filings in 12 months · 2 flags · $15K federal (possible match)
- RECURSION PHARMACEUTICALS, INC. · 174 SEC filings in 12 months · 1 flag
- GILEAD SCIENCES, INC. · 173 SEC filings in 12 months
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-26 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2026-10-23 filing S-8 · SEC EDGAR
- 2026-10-23 filing 424B4 · SEC EDGAR
- 2026-10-22 filing EFFECT · SEC EDGAR
- 2026-10-22 filing S-1MEF · SEC EDGAR
- 2026-10-22 filing CERT · SEC EDGAR
- 2026-10-20 filing 8-A12B · SEC EDGAR
- 2026-10-20 filing S-1/A · SEC EDGAR
- 2026-10-05 filing Registration (S-1) · SEC EDGAR
- 2026-08-27 filing DRS/A · SEC EDGAR
- 2026-07-02 filing DRS · SEC EDGAR
- 2026-06-25 filing D · SEC EDGAR
- 2024-05-23 filing D · SEC EDGAR
- 2021-09-16 filing D · SEC EDGAR
- 2020-03-17 filing D · SEC EDGAR
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-26 (within 30 days) 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-23 (within 30 days) S-8 filed
- 2026-10-23 (within 30 days) 424B4 filed
- 2026-10-22 (older) EFFECT filed
- 2026-10-22 (older) S-1MEF filed
- 2026-10-22 (older) CERT filed
- 2026-10-20 (older) 8-A12B filed
- 2026-10-20 (older) S-1/A filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:LYCA The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1806540 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | LYCA / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 843860514 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001806540 | SEC EDGAR / IRS |
| CUSIP | 55081P100 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001806540 | SEC EDGAR |
possible match: matched by name only, not merged (1)
Identifiers carried by records that share the company's exact name. Not merged into the identity above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| EPA FRS id | 110072006671 (LYCIA THERAPEUTICS INC) | name-exact:legal-name: same registered legal name as 'Lycia Therapeutics, Inc.' | EPA ECHO facilities |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-11-04 | SEC EDGAR company profile | as filed | 2026-11-22 03:06 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-04 | SEC EDGAR company profile | as filed | 2026-11-22 03:06 UTC | Report an error |
| State of incorporation | DE | 2026-11-04 | SEC EDGAR company profile | as filed | 2026-11-22 03:06 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-04 | SEC EDGAR company profile | as filed | 2026-11-22 03:06 UTC | Report an error |
| Business address | 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080 | 2026-11-04 | SEC EDGAR company profile | as filed | 2026-11-22 03:06 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-04 | SEC EDGAR company profile | as filed | 2026-11-22 03:06 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Form D total offering amount (D filed 2026-06-25) | $75,000,000 | 2026-06-25 | D | as filed | 2026-11-22 03:06 UTC | Report an error |
| Form D total amount sold (D filed 2026-06-25) | $75,000,000 | 2026-06-25 | D | as filed | 2026-11-22 03:06 UTC | Report an error |
| Form D industry group | Biotechnology | 2026-06-25 | D | as filed | 2026-11-22 03:06 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2026-06-25 | D | as filed | 2026-11-22 03:06 UTC | Report an error |
| Form D date of first sale | 2026-06-10 | 2026-06-25 | D | as filed | 2026-11-22 03:06 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-26 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-23 Filing S-8 filed
- 2026-10-23 Filing 424B4 filed
- 2026-10-22 Filing EFFECT filed
- 2026-10-22 Filing S-1MEF filed
- 2026-10-22 Filing CERT filed
- 2026-10-20 Filing 8-A12B filed
- 2026-10-20 Filing S-1/A filed
- 2026-10-05 Filing S-1 filed (DRS/A)
- 2026-08-27 Filing DRS/A filed
- 2026-07-02 Filing DRS filed
- 2026-06-25 Filing D filed
- 2026-04-23 Record earliest certified decision date in the file
- 2026-04-23 Record latest certified decision date in the file
- 2024-05-23 Filing D filed
- 2021-09-16 Filing D filed
- 2020-03-17 Filing D filed
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
EPA ECHO facilities (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchLYCIA THERAPEUTICS INC · exact legal name · sx:epa:110072006671 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
DOL H-1B (LCA) · WARN NOT HELD12. Labor
| Measure | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| Employer name (as filed) | Lycia Therapeutics, Inc. | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-22 03:06 UTC | Report an error |
| Certified LCAs | 1 | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-22 03:06 UTC | Report an error |
| Certified LCAs later withdrawn | 0 | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-22 03:06 UTC | Report an error |
| Total worker positions on certified LCAs | 1 | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-22 03:06 UTC | Report an error |
| Top job titles (title, LCA count) | Senior Research Associate I (1) | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-22 03:06 UTC | Report an error |
| Wage offered, annualized (n, min, median, max) | median $100,000 (range $100,000-$100,000, 1 filings) | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-22 03:06 UTC | Report an error |
| Worksite states | CA | 2026-06-30 | DOL OFLC LCA Disclosure Data (dataset) | 2026-11-22 03:06 UTC | Report an error |
Unconfirmed: these labor figures (positions, worksite states, certified LCAs later withdrawn) are as read from DOL's quarterly LCA disclosure file. Seraphix's independent second check of them is not finished (11-19); they are shown as filed, not as verified.
WARN layoff notices: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchLycia Therapeutics, Inc. · exact legal name · sx:ctgov:h3540043b6e2bc5f8 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1806540.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001806540. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.